Hudson Bay Capital Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-150,000
Closed -$1.77M 1419
2025
Q4
$1.77M Buy
+150,000
New +$1.93M 0.01% 730
2024
Q3
Sell
-30,000
Closed -$677K 889
2024
Q2
$677K Buy
+30,000
New +$786K ﹤0.01% 628
2018
Q4
Sell
-45,000
Closed -$1.77M 782
2018
Q3
$1.77M Buy
+45,000
New +$1.97M 0.02% 493
2017
Q2
Sell
-9,200
Closed -$354K 560
2017
Q1
$354K Buy
+9,200
New +$277K ﹤0.01% 728

Other funds holding CC

Hudson Bay Capital Management's CC Position: Q1 2026 in Review

Hudson Bay Capital Management increased its Chemours (CC) stake by 4,458% in Q1 2026, buying an estimated $1.19M and bringing the position to 70,050 shares worth $1.54M. The position accounts for 0.01% of the portfolio, ranked #807.

Hudson Bay Capital Management first reported a position in CC in Q1 2024 and has held it in 4 quarters since. The position peaked at $1.93M in Q3 2025. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Hudson Bay Capital Management held 70,050 shares of Chemours worth $1.54M as of Q1 2026.
  • Hudson Bay Capital Management bought 68,513 Chemours shares in Q1 2026, an estimated $1.19M.
  • Chemours made up 0.01% of Hudson Bay Capital Management's portfolio in Q1 2026, its #807 holding.
  • Hudson Bay Capital Management first reported a position in Chemours in Q1 2024 and has held it in 4 quarters since.
  • Hudson Bay Capital Management's Chemours position peaked at $1.93M in Q3 2025.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Hudson Bay Capital Management's 13F filing for Q1 2026, filed 13 May 2026.